Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Casson

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Fertility and Sterility|July 11, 1998
Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trialP R Casson, N Santoro, K Elkind-Hirsch, et al.
American Journal of Obstetrics and Gynecology|April 1, 1992
Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studiesJ E Buster, P R Casson, A B Straughn, et al.
Obstetrics and Gynecology|December 16, 1997
Effect of postmenopausal estrogen replacement on circulating androgensP R Casson, K E Elkind-Hirsch, J E Buster, et al.
American Journal of Obstetrics and Gynecology|December 1, 1993
Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal womenP R Casson, R N Andersen, H G Herrod, et al.
Fertility and Sterility|April 15, 1999
Fertilization after standard in vitro fertilization versus intracytoplasmic sperm injection in subfertile males using sibling oocytesM D Pisarska, P R Casson, P L Cisneros, et al.
Fertility and Sterility|May 1, 1995
Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal womenP R Casson, L C Faquin, F B Stentz, et al.
The New England Journal of Medicine|September 7, 2000
Transdermal testosterone treatment in women with impaired sexual function after oophorectomyJ L Shifren, G D Braunstein, J A Simon, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Fertility and Sterility|July 11, 1998
Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trialP R Casson, N Santoro, K Elkind-Hirsch, et al.
American Journal of Obstetrics and Gynecology|April 1, 1992
Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studiesJ E Buster, P R Casson, A B Straughn, et al.
Obstetrics and Gynecology|December 16, 1997
Effect of postmenopausal estrogen replacement on circulating androgensP R Casson, K E Elkind-Hirsch, J E Buster, et al.
American Journal of Obstetrics and Gynecology|December 1, 1993
Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal womenP R Casson, R N Andersen, H G Herrod, et al.
Fertility and Sterility|April 15, 1999
Fertilization after standard in vitro fertilization versus intracytoplasmic sperm injection in subfertile males using sibling oocytesM D Pisarska, P R Casson, P L Cisneros, et al.
Fertility and Sterility|May 1, 1995
Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal womenP R Casson, L C Faquin, F B Stentz, et al.
The New England Journal of Medicine|September 7, 2000
Transdermal testosterone treatment in women with impaired sexual function after oophorectomyJ L Shifren, G D Braunstein, J A Simon, et al.
Pageof 3